The North America Urinary Incontinence Devices Market would witness market growth of 10.3% CAGR during the forecast period (2018 – 2024). Urinary incontinence is an unintentional leakage of urine, and it is differentiated into four types, namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Urinary incontinence is most commonly found in women. Development of innovative urinary catheters, growing preference for surgical treatment for urinary incontinence is the factors that drive the growth of the market during the forecast period. In addition, rise in geriatric population that normally suffers from urinary incontinence or incontinence associated with chronic conditions (kidney stones, miscarriages, paralysis, and neuromuscular injury) would be a factor that would drive the market growth.
Based on product, the market report segments the market into Vaginal Slings, Urinary Catheters, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Other Devices. The category segment includes External Urinary Incontinence Devices and Internal Urinary Incontinence Devices. The Incontinence Type segment covers Stress Incontinence, Urge Incontinence, Overflow Incontinence, and Functional Incontinence. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants
Our reports have been used by over 10K customers, including:
Big changes: Increased external competition from clinics and hospitals has hurt industry Abstract Weight Loss Service Franchises This industry includes franchised establishments that provide nonmedical services to assist clients with losing weight or maintaining a desired weight level. Reports in IBISWorld’s...
Reishi Mushroom Market by Form (Liquid and Powder), End Use (Pharmaceutical, Nutraceutical & Dietary Supplements, and Cosmetics & Personal Care), and Nature (Organic and Conventional): Global Opportunity Analysis and Industry Forecast, 2021–2027 Reishi mushroom is a fungus, which belongs to the family Polyporaceae (or...
The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period.
The OTC drugs market is innovation-driven and relies on the advent of innovative drugs for different disease complexities and vary in their degree of intensity, and efficacy. The product innovations in OTC...
200 pages •
By Future Market Insight Global & Consulting Pvt Ltd
• Oct 2020
A recent market study published on the customized premix market offers global industry analysis for 2015-2019 & opportunity assessment for 2020–2030. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects...
35 pages •
By Euromonitor International
• Oct 2020
In light of Coronavirus, Johnson & Johnson is expected to perform above industry average in 2020, boosted by the successes of its analgesics and cough, cold and allergy remedies brands. While its OTC portfolio is well positioned to see growth at the global level, J&J would be wise to diversify its sales in high-growth economies and expand...
The North America OTC drug and dietary supplement market was valued at US$ 131,818.3 million in 2019 and is projected to reach US$ 224,349.5 million by 2027; it is expected to grow at a CAGR of 7.0% during 2020–2027. The growth of the OTC drug and dietary supplement market is mainly attributed to the factors such as rising awareness...
KEY INSIGHTS Gastro-esophageal reflux disease (GERD) is a chronic digestive disorder that occurs due to complications arising in the esophagus.The market is responsible for producing and distributing the drugs and devices required for its optimized cure and accurate diagnosis respectively. The global GERD drug and...
KEY FINDINGS The North American market for GERD drugs and devices is the largest in the world and is supposed to grow with a 0.78% CAGR for the forecast years 2019-2027. The United States of America and Canada are taken into consideration for the market analysis in this report. MARKET INSIGHTS The...
KEY FINDINGS The North America chronic idiopathic constipation drug market is expected to grow at a CAGR of 6.95% over the forecast period of 2018-2026. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing increasing elderly population are some of the factors driving...
Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It designs, researches, develops, manufactures and sells pharmaceuticals and consumer health products. The company provides prescription pharmaceuticals, such as anticoagulants; treatments for cancer, hemophilia, multiple sclerosis,...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.